Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Activity) (Details) - Stock Settled Stock Appreciation Rights SARS [Member] - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2018
Number of Rights
Number of Rights, Outstanding at beginning of year (in rights)	586
Number of Rights, Exercised (in rights)	(215)
Number of Rights, Granted (in rights)	180	157	185
Number of Rights, Forfeited (in rights)	(12)
Number of Rights, Outstanding at end of year (in rights)	539	586
Number of Rights, Exercisable and vested at end of year (in rights)	208
Number of Rights, Vested and expected to vest at end of year (in rights)	511
Weighted Average Exercise Price
Weighted Average Exercise Price, Outstanding at beginning of year (in dollars per share)	$ 128.23
Weighted Average Exercise Price, Exercised (in dollars per share)	113.89
Weighted Average Exercise Price, Granted (in dollars per share)	153.73
Weighted Average Exercise Price, Forfeited (in dollars per share)	140.29
Weighted Average Exercise Price, Outstanding at end of year (in dollars per share)	142.16	$ 128.23
Weighted Average Exercise Price, Exercisable and vested at end of year (in dollars per share)	131.21
Weighted Average Exercise Price, Vested and expected to vest at end of year (in dollars per share)	$ 143.23
Weighted Average Remaining Contractual Life in Years, Outstanding at end of year	3 years 4 months 24 days
Weighted Average Remaining Contractual Life in Years, Exercisable and vested at end of year	2 years 4 months 20 days
Weighted Average Remaining Contractual Life in Years, Vested and expected to vest at end of year	3 years 5 months 19 days
Aggregate Intrinsic Value, Outstanding at end of year	$ 6,976
Aggregate Intrinsic Value, Exercisable and vested at end of year	4,973
Aggregate Intrinsic Value, Vested and expected to vest at end of year	$ 6,072